Detecting and treating COVID-19
OptumLabs is collaborating across health care and technology to accelerate COVID-19 research and advance patient care.
Collaborating to combat COVID-19
OptumLabs is bringing together our expertise in science, clinical research and technology to combat COVID-19 by providing the health care system with new insights and solutions. To accomplish our goals, our research is enhanced by collaboration across diverse industries and fields.
The latest COVID-19 news
Partnership to study COVID-19 antibody drug
OptumLabs and Eli Lilly have teamed up to further study the effects of antibody therapy for high-risk COVID-19 patients.
New data about accuracy of self-administered COVID-19 tests
An OptumLabs study found self-administered COVID-19 tests are as accurate as those administered by clinicians.
Free coronavirus screening app offered to companies
OptumLabs and Microsoft have launched a new free app called ProtectWell to help employees return to work safely.
OptumLabs ships flu kits to Medicare recipients
To mitigate the effects of a possible COVID-19/influenza twindemic, OptumLabs is sending 200,000 kits directly to at-risk patients.
J&J taps OptumLabs to cut vaccine trial time by half
Johnson & Johnson is turning to data experts at OptumLabs to accelerate recruitment for their vaccine trial.